In the meantime, feel free to check out the Global Health Conversations podcast on Apple Podcasts or Spotify. And, sign up here for the free fortnightly Newsletter for articles, public health resources, updates, interviews and more. Or, feel free to stay here and catch up on the archived articles here from 2016 - 2019. Christiana
I am excited to announce that the Global Health Conversations Podcast launches in April 2023. Please click here and subscribe to my monthly newsletter to be notified :)
The term antibiotic was first coined in 1941 by Selman Waksman to describe any small molecule made by a microbe that antagonizes the growth of other microbes. The antibiotic age occurred with the development of other agents such as tetracycline, streptomycin and chloramphenicol from soil bacteria; amongst others. Modern medicine ...
In my opinion, the consequences of increasing incidence of obesity fall into four key dimensions: individual, societal, structural and economic. This is Part 4 of my Obesity in the UK series. If you missed Parts 1, 2, or 3 - mainly dealing with the consequential factors of obesity.
Bi-weekly writing on pandemic preparedness, pharma economics, multilateralism, and the quiet machinery of global health — from a drug discovery scientist working at the intersection of science and policy.
A drug discovery scientist by training and a global public health writer by practice. I write to make sense of the systems, money, and politics that shape who gets healthcare, and who doesn’t.
I work in R&D at the intersection of biomanufacturing, health economics, health security, and pandemic preparedness — across both private and public sectors. Global Health Conversations is where I think out loud: connecting the dots between WHO negotiations, pharma financials, and the long arc of multilateralism.
Based between Geneva and London. Currently focused on building bridges between scientific practice and the policy table.
Published bi-weekly. A mix of long-reads on policy negotiations, breakdowns of pharma financials, and quieter reflections from inside the global health conversation.
A pre-Assembly read on the pandemic accord, IHR amendments, and the negotiations that will shape the next decade.
Read on SubstackThe accord is signed. What it actually means for surveillance, technology transfer, and equitable access — and what’s still unresolved.
Read on SubstackA paradox: prevention is cheaper, more effective, and more humane. So why does the money never seem to find it?
Read on SubstackBusiness as (un)usual: how tariff regimes are reshaping pharmaceutical supply chains and access.
Read on SubstackSemaglutides, the economy, and you: a hard look at the costs hidden behind the GLP-1 boom.
Read on SubstackOutbreaks, genomic surveillance, and dual-use concerns — where two communities still struggle to speak the same language.
Read on SubstackThe threads that run through everything I write — the questions I keep coming back to, sometimes from new angles.
The mechanics, politics, and human moments inside the World Health Assembly and beyond.
What “100 days” really takes — surveillance, manufacturing, and the politics of readiness.
Quarterly financial breakdowns, drug pricing, and what the numbers say that press releases don’t.
The space where biosecurity, dual-use research, and outbreak response actually meet.
What it takes to actually make medicines — and why distributed capacity matters.
Quieter pieces — on conferences, classical music, and what global health work asks of you.
I work with newsrooms, NGOs, and convening organizations on long-form analysis, briefings, and stage commentary. Below are the most common ways we end up working together.
Long-form essays, briefing notes, and policy explainers for organizations that need rigorous, accessible global health analysis.
Discuss a commission →Keynotes, panel discussions, and moderation on pandemic preparedness, pharma economics, and multilateral health governance.
Invite me to speak →Selective consulting and advisory work for foundations, NGOs, and biomanufacturing programs working at the science-policy edge.
Start a conversation →For commissions, speaking, advisory work — or just to say hello — write to me directly. I read every message.
